Skip to main content

Arbutus Biopharma Corp

ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001447028

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Arbutus Biopharma Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of ABUS: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1314144+17
Shares96.7M11.8M101.1M+16.2M (+19.0%)
Value$298.4M$36.4M$389.2M+$127.2M (+48.5%)

4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Arbutus Biopharma Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ABUS in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.12,218,759$47.0M0.00%
Swiss National Bank276,300$1.06M0.00%
UBS Asset Management Americas Inc195,843$754.0K0.00%
Qube Research & Technologies Ltd170,287$655.6K0.00%
Rafferty Asset Management, LLC115,021$442.8K0.00%
State of Wisconsin Investment Board98,557$379.4K0.00%
Squarepoint Ops LLC64,808$249.5K0.00%
Rockefeller Capital Management L.P.63,000$242.6K0.00%
Janus Henderson Group PLC60,900$234.2K0.00%
Cetera Investment Advisers54,357$209.3K0.00%
SG Americas Securities, LLC52,869$204.0K0.00%
Options Solutions, LLC40,932$157.6K0.08%
Arizona State Retirement System40,755$156.9K0.00%
Intech Investment Management LLC36,852$141.9K0.00%
Teacher Retirement System of Texas35,500$137.0K0.00%
AQR Capital Management LLC33,718$129.8K0.00%
GTS Securities LLC28,817$110.9K0.00%
Profund Advisors LLC24,812$95.5K0.00%
Colony Group, LLC17,821$68.6K0.00%
State of Wyoming15,944$61.4K0.01%
Helen Stephens Group, LLC13,000$50.0K0.02%
Pictet Asset Management Holding SA12,920$49.7K0.00%
LPL Financial LLC11,347$43.7K0.00%
Eastern Bank5,000$19.3K0.00%
Avion Wealth1,500$5.00K0.00%
Capital Performance Advisors LLP545$2.10K0.00%
Sterling Capital Management LLC161$6200.00%
Aster Capital Management (DIFC) Ltd130$5010.00%
Federated Hermes, Inc.3$120.00%

Sold out (12)

Institutions that held Arbutus Biopharma Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ABUS in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Toroso Investments, LLC41,271$127.5K
National Philanthropic Trust36,211$111.9K
Verition Fund Management LLC23,927$73.9K
Cowen and Company, LLC20,000$61.8K
Prudential Financial Inc14,975$46.3K
Arete Wealth Advisors, LLC15,000$46.0K
HSBC Holdings PLC13,449$40.9K
Kestra Advisory Services, LLC10,800$33.4K
Covestor Ltd6,700$21.0K
FNY Investment Advisers, LLC3,800$11.0K
Central Trust Co100$309
Opal Wealth Advisors, LLC100$309

Not filed for Q3 2024 yet (4)

Institutions that held Arbutus Biopharma Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABUS in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.11,552,066$35.7M
Susquehanna Fundamental Investments, LLC208,152$643.2K
Buckingham Strategic Wealth, LLC17,820$55.1K
Benjamin F. Edwards & Company, Inc.1,088$3.00K